Funder
U.S. Department of Veterans Affairs
National Institute on Drug Abuse
Publisher
Springer Science and Business Media LLC
Reference32 articles.
1. Chen CM, Yoon Y. Surveillance Report #118: Liver Cirrhosis Mortality in the United States: National, State, and Regional Trends, 2000–2019. 2022; https://www.niaaa.nih.gov/sites/default/files/surveillance-report118.pdf. Accessed August 16, 2023.
2. GBD 2017 Causes of Death Collaborators. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1736–1788.
3. Morales BP, Planas R, Bartoli R et al. HEPACONTROL. A program that reduces early readmissions, mortality at 60 days, and healthcare costs in decompensated cirrhosis. Dig Liver Dis. 2018;50(1):76–83.
4. Gaspar R, Rodrigues S, Silva M et al. Predictive models of mortality and hospital readmission of patients with decompensated liver cirrhosis. Dig Liver Dis. 2019;51(10):1423–1429.
5. Serper M, Kaplan DE, Shults J et al. Quality measures, all-cause mortality, and health care use in a national cohort of veterans with cirrhosis. Hepatology. 2019;70(6):2062–2074.